Trials / Conditions / Adult Leiomyosarcoma

Adult Leiomyosarcoma

8 registered clinical trials studyying Adult Leiomyosarcoma.

Status	Trial	Sponsor	Phase
Completed	Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma NCT01532687	OHSU Knight Cancer Institute	Phase 2
Completed	Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced NCT01154452	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metasta NCT00720174	National Cancer Institute (NCI)	Phase 1
Completed	AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma NCT00659360	National Cancer Institute (NCI)	Phase 2
Completed	Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft NCT00346164	Children's Oncology Group	Phase 3
Completed	Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma NCT00245102	National Cancer Institute (NCI)	Phase 2
Completed	Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma NCT00112463	National Cancer Institute (NCI)	Phase 2
Terminated	S9624 Ifosfamide in Treating Patients With Meningeal Tumors NCT00003292	SWOG Cancer Research Network	Phase 2